DrugPatentWatch Database Preview

Drugs in Development Information for Perifosine

US Patents	640
International Patents	7,112
US Patent Applications	1,629
WIPO Patent Applications	1,344
Japanese Patent Applications	2
Clinical Trial Progress	Phase 3 (2009-12-01)
Vendors	77

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Perifosine	➤ Sign Up	Compounds and their methods of use	Agios Pharmaceuticals, Inc. (Cambridge, MA)	➤ Sign Up
Perifosine	➤ Sign Up	Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers	IMMATICS BIOTECHNOLOGIES GMBH (Tuebingen, DE)	➤ Sign Up
Perifosine	➤ Sign Up	Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity	The University of North Carolina at Chapel Hill (Chapel Hill, NC)	➤ Sign Up
Perifosine	➤ Sign Up	Pyrrolidinone derivatives as MetAP-2 inhibitors	Merck Patent GmbH (Darmstadt, DE)	➤ Sign Up
Perifosine	➤ Sign Up	B7 family member zB7H6 and related compositions and methods	Zymogenetics, Inc. (Princeton, NJ)	➤ Sign Up
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Perifosine	Australia	2015231053	2034-03-21	➤ Sign Up
Perifosine	Brazil	112016021620	2034-03-21	➤ Sign Up
Perifosine	Canada	2943339	2034-03-21	➤ Sign Up
Perifosine	China	106231900	2034-03-21	➤ Sign Up
Perifosine	Eurasian Patent Organization	201691896	2034-03-21	➤ Sign Up
Drugname	Country	Document Number	Estimated Expiration	Related US Patent